104360-70-5

Basic information

• Product Name: DIAZEPAM BINDING INHIBITOR FRAGMENT (HUMAN)
• Synonyms: DBI FRAGMENT (HUMAN);DIAZEPAM BINDING INHIBITOR [DBI] FRAGMENT 51-70;DIAZEPAM BINDING INHIBITOR FRAGMENT (HUMAN);GLN-ALA-THR-VAL-GLY-ASP-ILE-ASN-THR-GLU-ARG-PRO-GLY-MET-LEU-ASP-PHE-THR-GLY-LYS;GLN-ALA-THR-VAL-GLY-ASP-ILE-ASN-THR-GLU-ARG-PRO-GLY-MET-LEU-ASP-PHE-THR-GLY-LYS HUMAN;FRAGMENT (HUMAN) DBI;H-GLN-ALA-THR-VAL-GLY-ASP-ILE-ASN-THR-GLU-ARG-PRO-GLY-MET-LEU-ASP-PHE-THR-GLY-LYS-OH;QATVGDINTERPGMLDFTGK
• CAS NO: 104360-70-5
• Molecular Formula: C91H148N26O32S
• Molecular Weight: 2150.37
• Product Categories: Miscellaneous Compounds;Obesity
• Mol File: 104360-70-5.mol
• Article Data: 0

Chemical Properties

• Appearance: /
• Density: 1.50±0.1 g/cm3(Predicted)
• Storage Temp.: −20°C
• CAS DataBase Reference: DIAZEPAM BINDING INHIBITOR FRAGMENT (HUMAN)(CAS DataBase Reference)
• NIST Chemistry Reference: DIAZEPAM BINDING INHIBITOR FRAGMENT (HUMAN)(104360-70-5)
• EPA Substance Registry System: DIAZEPAM BINDING INHIBITOR FRAGMENT (HUMAN)(104360-70-5)

Safety Data

• WGK Germany: 3
• Hazardous Substances Data: 104360-70-5(Hazardous Substances Data)

Usage

General Description

The DIAZEPAM BINDING INHIBITOR FRAGMENT (HUMAN) is a chemical fragment that acts as an inhibitor of the binding of diazepam, a medication used to treat anxiety, seizures, and alcohol withdrawal, to its target in the human body. This fragment is designed to specifically block the interaction between diazepam and its binding site, potentially leading to the development of new medications that can modulate the effects of diazepam and provide alternative treatments for conditions that are currently managed with this drug. Additionally, studying the interaction between this fragment and diazepam binding may enhance our understanding of the biological mechanisms involved, potentially leading to the development of more effective drugs with fewer side effects.